0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Sodium Iodide (131I) Diagnostic Capsules Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: October 2025
|
Report Code: QYRE-Auto-32D17126
Home | Market Reports | Health| Nutrition| Vitamins & Supplements
Global Sodium Iodide 131I Diagnostic Capsules Market Research Report 2024
BUY CHAPTERS

Global Sodium Iodide (131I) Diagnostic Capsules Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-32D17126
Report
October 2025
Pages:114
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Sodium Iodide (131I) Diagnostic Capsules Market

The global Sodium Iodide (131I) Diagnostic Capsules market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Sodium iodide (131I) diagnostic capsule is a radioactive drug used for the diagnosis of thyroid disease-related diseases. Iodine-131 (131I, I-131) is an important radioisotope of iodine discovered by Glenn Seaborg and John Livingood in 1938 at the University of California, Berkeley. It has a radioactive decay half-life of about eight days. It is associated with nuclear energy, medical diagnostic and treatment procedures, and natural gas production.
From a downstream perspective, Hyperthyroidism accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Sodium Iodide (131I) Diagnostic Capsules leading manufacturers including Jubilant Radiopharma, Beijing Atom High-Tech, Curium Pharma, NTP Radioisotopes, PDRadiopharma, etc., dominate supply; the top five capture approximately % of global revenue, with Jubilant Radiopharma leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Sodium Iodide (131I) Diagnostic Capsules market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Specification and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Sodium Iodide (131I) Diagnostic Capsules Market Report

Report Metric Details
Report Name Sodium Iodide (131I) Diagnostic Capsules Market
Segment by Specification
  • 0.333MBq
  • 3.7MBq
  • Others
Segment by Application
  • Hyperthyroidism
  • Thyroid Cancer
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Jubilant Radiopharma, Beijing Atom High-Tech, Curium Pharma, NTP Radioisotopes, PDRadiopharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Sodium Iodide (131I) Diagnostic Capsules study scope, segments the market by Specification and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Specification, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Specification, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Specification, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Specification, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Specification, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Sodium Iodide (131I) Diagnostic Capsules Market report?

Ans: The main players in the Sodium Iodide (131I) Diagnostic Capsules Market are Jubilant Radiopharma, Beijing Atom High-Tech, Curium Pharma, NTP Radioisotopes, PDRadiopharma

What are the Application segmentation covered in the Sodium Iodide (131I) Diagnostic Capsules Market report?

Ans: The Applications covered in the Sodium Iodide (131I) Diagnostic Capsules Market report are Hyperthyroidism, Thyroid Cancer

1 Study Coverage
1.1 Introduction to Sodium Iodide (131I) Diagnostic Capsules: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Specification
1.2.1 Global Sodium Iodide (131I) Diagnostic Capsules Market Size by Specification, 2020 VS 2024 VS 2031
1.2.2 0.333MBq
1.2.3 3.7MBq
1.2.4 Others
1.3 Market Segmentation by Application
1.3.1 Global Sodium Iodide (131I) Diagnostic Capsules Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hyperthyroidism
1.3.3 Thyroid Cancer
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Sodium Iodide (131I) Diagnostic Capsules Revenue Estimates and Forecasts 2020-2031
2.2 Global Sodium Iodide (131I) Diagnostic Capsules Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Sodium Iodide (131I) Diagnostic Capsules Sales Estimates and Forecasts 2020-2031
2.4 Global Sodium Iodide (131I) Diagnostic Capsules Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Sodium Iodide (131I) Diagnostic Capsules Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Sodium Iodide (131I) Diagnostic Capsules Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 0.333MBq Market Size by Manufacturers
3.5.2 3.7MBq Market Size by Manufacturers
3.5.3 Others Market Size by Manufacturers
3.6 Global Sodium Iodide (131I) Diagnostic Capsules Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Sodium Iodide (131I) Diagnostic Capsules Sales Performance by Specification
4.1.1 Global Historical and Forecasted Sales by Specification (2020-2031)
4.1.2 Global Sales Market Share by Specification (2020-2031)
4.2 Global Sodium Iodide (131I) Diagnostic Capsules Revenue Trends by Specification
4.2.1 Global Historical and Forecasted Revenue by Specification (2020-2031)
4.2.2 Global Revenue Market Share by Specification (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Specification (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Sodium Iodide (131I) Diagnostic Capsules Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Sodium Iodide (131I) Diagnostic Capsules Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Sodium Iodide (131I) Diagnostic Capsules Sales and Revenue by Specification (2020-2031)
6.4 North America Sodium Iodide (131I) Diagnostic Capsules Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Sodium Iodide (131I) Diagnostic Capsules Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Sodium Iodide (131I) Diagnostic Capsules Sales and Revenue by Specification (2020-2031)
7.4 Europe Sodium Iodide (131I) Diagnostic Capsules Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Sodium Iodide (131I) Diagnostic Capsules Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Sodium Iodide (131I) Diagnostic Capsules Sales and Revenue by Specification (2020-2031)
8.4 Asia-Pacific Sodium Iodide (131I) Diagnostic Capsules Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Sodium Iodide (131I) Diagnostic Capsules Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Sodium Iodide (131I) Diagnostic Capsules Sales and Revenue by Specification (2020-2031)
9.4 Central and South America Sodium Iodide (131I) Diagnostic Capsules Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Sodium Iodide (131I) Diagnostic Capsules Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Sodium Iodide (131I) Diagnostic Capsules Sales and Revenue by Specification (2020-2031)
10.4 Middle East and Africa Sodium Iodide (131I) Diagnostic Capsules Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Sodium Iodide (131I) Diagnostic Capsules Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Jubilant Radiopharma
11.1.1 Jubilant Radiopharma Corporation Information
11.1.2 Jubilant Radiopharma Business Overview
11.1.3 Jubilant Radiopharma Sodium Iodide (131I) Diagnostic Capsules Product Models, Descriptions and Specifications
11.1.4 Jubilant Radiopharma Sodium Iodide (131I) Diagnostic Capsules Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Jubilant Radiopharma Sodium Iodide (131I) Diagnostic Capsules Sales by Product in 2024
11.1.6 Jubilant Radiopharma Sodium Iodide (131I) Diagnostic Capsules Sales by Application in 2024
11.1.7 Jubilant Radiopharma Sodium Iodide (131I) Diagnostic Capsules Sales by Geographic Area in 2024
11.1.8 Jubilant Radiopharma Sodium Iodide (131I) Diagnostic Capsules SWOT Analysis
11.1.9 Jubilant Radiopharma Recent Developments
11.2 Beijing Atom High-Tech
11.2.1 Beijing Atom High-Tech Corporation Information
11.2.2 Beijing Atom High-Tech Business Overview
11.2.3 Beijing Atom High-Tech Sodium Iodide (131I) Diagnostic Capsules Product Models, Descriptions and Specifications
11.2.4 Beijing Atom High-Tech Sodium Iodide (131I) Diagnostic Capsules Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Beijing Atom High-Tech Sodium Iodide (131I) Diagnostic Capsules Sales by Product in 2024
11.2.6 Beijing Atom High-Tech Sodium Iodide (131I) Diagnostic Capsules Sales by Application in 2024
11.2.7 Beijing Atom High-Tech Sodium Iodide (131I) Diagnostic Capsules Sales by Geographic Area in 2024
11.2.8 Beijing Atom High-Tech Sodium Iodide (131I) Diagnostic Capsules SWOT Analysis
11.2.9 Beijing Atom High-Tech Recent Developments
11.3 Curium Pharma
11.3.1 Curium Pharma Corporation Information
11.3.2 Curium Pharma Business Overview
11.3.3 Curium Pharma Sodium Iodide (131I) Diagnostic Capsules Product Models, Descriptions and Specifications
11.3.4 Curium Pharma Sodium Iodide (131I) Diagnostic Capsules Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Curium Pharma Sodium Iodide (131I) Diagnostic Capsules Sales by Product in 2024
11.3.6 Curium Pharma Sodium Iodide (131I) Diagnostic Capsules Sales by Application in 2024
11.3.7 Curium Pharma Sodium Iodide (131I) Diagnostic Capsules Sales by Geographic Area in 2024
11.3.8 Curium Pharma Sodium Iodide (131I) Diagnostic Capsules SWOT Analysis
11.3.9 Curium Pharma Recent Developments
11.4 NTP Radioisotopes
11.4.1 NTP Radioisotopes Corporation Information
11.4.2 NTP Radioisotopes Business Overview
11.4.3 NTP Radioisotopes Sodium Iodide (131I) Diagnostic Capsules Product Models, Descriptions and Specifications
11.4.4 NTP Radioisotopes Sodium Iodide (131I) Diagnostic Capsules Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 NTP Radioisotopes Sodium Iodide (131I) Diagnostic Capsules Sales by Product in 2024
11.4.6 NTP Radioisotopes Sodium Iodide (131I) Diagnostic Capsules Sales by Application in 2024
11.4.7 NTP Radioisotopes Sodium Iodide (131I) Diagnostic Capsules Sales by Geographic Area in 2024
11.4.8 NTP Radioisotopes Sodium Iodide (131I) Diagnostic Capsules SWOT Analysis
11.4.9 NTP Radioisotopes Recent Developments
11.5 PDRadiopharma
11.5.1 PDRadiopharma Corporation Information
11.5.2 PDRadiopharma Business Overview
11.5.3 PDRadiopharma Sodium Iodide (131I) Diagnostic Capsules Product Models, Descriptions and Specifications
11.5.4 PDRadiopharma Sodium Iodide (131I) Diagnostic Capsules Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 PDRadiopharma Sodium Iodide (131I) Diagnostic Capsules Sales by Product in 2024
11.5.6 PDRadiopharma Sodium Iodide (131I) Diagnostic Capsules Sales by Application in 2024
11.5.7 PDRadiopharma Sodium Iodide (131I) Diagnostic Capsules Sales by Geographic Area in 2024
11.5.8 PDRadiopharma Sodium Iodide (131I) Diagnostic Capsules SWOT Analysis
11.5.9 PDRadiopharma Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Sodium Iodide (131I) Diagnostic Capsules Industry Chain
12.2 Sodium Iodide (131I) Diagnostic Capsules Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Sodium Iodide (131I) Diagnostic Capsules Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Sodium Iodide (131I) Diagnostic Capsules Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Sodium Iodide (131I) Diagnostic Capsules Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Sodium Iodide (131I) Diagnostic Capsules Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
 Table 1. Global Sodium Iodide (131I) Diagnostic Capsules Market Size Growth Rate by Specification, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Sodium Iodide (131I) Diagnostic Capsules Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Sodium Iodide (131I) Diagnostic Capsules Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Sodium Iodide (131I) Diagnostic Capsules Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Sodium Iodide (131I) Diagnostic Capsules Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Sodium Iodide (131I) Diagnostic Capsules Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
 Table 7. Global Sodium Iodide (131I) Diagnostic Capsules Sales by Region (2020-2025) & (K Units)
 Table 8. Global Sodium Iodide (131I) Diagnostic Capsules Sales by Region (2026-2031) & (K Units)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Sodium Iodide (131I) Diagnostic Capsules Sales by Manufacturers (2020-2025) & (K Units)
 Table 11. Global Sodium Iodide (131I) Diagnostic Capsules Sales Share by Manufacturers (2020-2025)
 Table 12. Global Sodium Iodide (131I) Diagnostic Capsules Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Sodium Iodide (131I) Diagnostic Capsules Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Sodium Iodide (131I) Diagnostic Capsules by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sodium Iodide (131I) Diagnostic Capsules as of 2024)
 Table 16. Global Sodium Iodide (131I) Diagnostic Capsules Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Sodium Iodide (131I) Diagnostic Capsules Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
 Table 18. Key Manufacturers Sodium Iodide (131I) Diagnostic Capsules Manufacturing Base and Headquarters
 Table 19. Global Sodium Iodide (131I) Diagnostic Capsules Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Sodium Iodide (131I) Diagnostic Capsules Sales by Specification (2020-2025) & (K Units)
 Table 23. Global Sodium Iodide (131I) Diagnostic Capsules Sales by Specification (2026-2031) & (K Units)
 Table 24. Global Sodium Iodide (131I) Diagnostic Capsules Revenue by Specification (2020-2025) & (US$ Million)
 Table 25. Global Sodium Iodide (131I) Diagnostic Capsules Revenue by Specification (2026-2031) & (US$ Million)
 Table 26. Global Sodium Iodide (131I) Diagnostic Capsules ASP by Specification (2020-2031) & (US$/Unit)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Sodium Iodide (131I) Diagnostic Capsules Sales by Application (2020-2025) & (K Units)
 Table 29. Global Sodium Iodide (131I) Diagnostic Capsules Sales by Application (2026-2031) & (K Units)
 Table 30. Sodium Iodide (131I) Diagnostic Capsules High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Sodium Iodide (131I) Diagnostic Capsules Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Sodium Iodide (131I) Diagnostic Capsules Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Sodium Iodide (131I) Diagnostic Capsules ASP by Application (2020-2031) & (US$/Unit)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Sodium Iodide (131I) Diagnostic Capsules Growth Accelerators and Market Barriers
 Table 37. North America Sodium Iodide (131I) Diagnostic Capsules Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Sodium Iodide (131I) Diagnostic Capsules Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Sodium Iodide (131I) Diagnostic Capsules Growth Accelerators and Market Barriers
 Table 40. Europe Sodium Iodide (131I) Diagnostic Capsules Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Sodium Iodide (131I) Diagnostic Capsules Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Sodium Iodide (131I) Diagnostic Capsules Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Sodium Iodide (131I) Diagnostic Capsules Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Sodium Iodide (131I) Diagnostic Capsules Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Sodium Iodide (131I) Diagnostic Capsules Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Sodium Iodide (131I) Diagnostic Capsules Investment Opportunities and Key Challenges
 Table 47. Central and South America Sodium Iodide (131I) Diagnostic Capsules Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Sodium Iodide (131I) Diagnostic Capsules Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Sodium Iodide (131I) Diagnostic Capsules Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. Jubilant Radiopharma Corporation Information
 Table 51. Jubilant Radiopharma Description and Major Businesses
 Table 52. Jubilant Radiopharma Product Models, Descriptions and Specifications
 Table 53. Jubilant Radiopharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 54. Jubilant Radiopharma Sales Value Proportion by Product in 2024
 Table 55. Jubilant Radiopharma Sales Value Proportion by Application in 2024
 Table 56. Jubilant Radiopharma Sales Value Proportion by Geographic Area in 2024
 Table 57. Jubilant Radiopharma Sodium Iodide (131I) Diagnostic Capsules SWOT Analysis
 Table 58. Jubilant Radiopharma Recent Developments
 Table 59. Beijing Atom High-Tech Corporation Information
 Table 60. Beijing Atom High-Tech Description and Major Businesses
 Table 61. Beijing Atom High-Tech Product Models, Descriptions and Specifications
 Table 62. Beijing Atom High-Tech Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 63. Beijing Atom High-Tech Sales Value Proportion by Product in 2024
 Table 64. Beijing Atom High-Tech Sales Value Proportion by Application in 2024
 Table 65. Beijing Atom High-Tech Sales Value Proportion by Geographic Area in 2024
 Table 66. Beijing Atom High-Tech Sodium Iodide (131I) Diagnostic Capsules SWOT Analysis
 Table 67. Beijing Atom High-Tech Recent Developments
 Table 68. Curium Pharma Corporation Information
 Table 69. Curium Pharma Description and Major Businesses
 Table 70. Curium Pharma Product Models, Descriptions and Specifications
 Table 71. Curium Pharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 72. Curium Pharma Sales Value Proportion by Product in 2024
 Table 73. Curium Pharma Sales Value Proportion by Application in 2024
 Table 74. Curium Pharma Sales Value Proportion by Geographic Area in 2024
 Table 75. Curium Pharma Sodium Iodide (131I) Diagnostic Capsules SWOT Analysis
 Table 76. Curium Pharma Recent Developments
 Table 77. NTP Radioisotopes Corporation Information
 Table 78. NTP Radioisotopes Description and Major Businesses
 Table 79. NTP Radioisotopes Product Models, Descriptions and Specifications
 Table 80. NTP Radioisotopes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 81. NTP Radioisotopes Sales Value Proportion by Product in 2024
 Table 82. NTP Radioisotopes Sales Value Proportion by Application in 2024
 Table 83. NTP Radioisotopes Sales Value Proportion by Geographic Area in 2024
 Table 84. NTP Radioisotopes Sodium Iodide (131I) Diagnostic Capsules SWOT Analysis
 Table 85. NTP Radioisotopes Recent Developments
 Table 86. PDRadiopharma Corporation Information
 Table 87. PDRadiopharma Description and Major Businesses
 Table 88. PDRadiopharma Product Models, Descriptions and Specifications
 Table 89. PDRadiopharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. PDRadiopharma Sales Value Proportion by Product in 2024
 Table 91. PDRadiopharma Sales Value Proportion by Application in 2024
 Table 92. PDRadiopharma Sales Value Proportion by Geographic Area in 2024
 Table 93. PDRadiopharma Sodium Iodide (131I) Diagnostic Capsules SWOT Analysis
 Table 94. PDRadiopharma Recent Developments
 Table 95. Key Raw Materials Distribution
 Table 96. Raw Materials Key Suppliers
 Table 97. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 98. Milestones in Production Technology Evolution
 Table 99. Distributors List
 Table 100. Market Trends and Market Evolution
 Table 101. Market Drivers and Opportunities
 Table 102. Market Challenges, Risks, and Restraints
 Table 103. Research Programs/Design for This Report
 Table 104. Key Data Information from Secondary Sources
 Table 105. Key Data Information from Primary Sources


List of Figures
 Figure 1. Sodium Iodide (131I) Diagnostic Capsules Product Picture
 Figure 2. Global Sodium Iodide (131I) Diagnostic Capsules Market Size Growth Rate by Specification, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. 0.333MBq Product Picture
 Figure 4. 3.7MBq Product Picture
 Figure 5. Others Product Picture
 Figure 6. Global Sodium Iodide (131I) Diagnostic Capsules Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 7. Hyperthyroidism
 Figure 8. Thyroid Cancer
 Figure 9. Sodium Iodide (131I) Diagnostic Capsules Report Years Considered
 Figure 10. Global Sodium Iodide (131I) Diagnostic Capsules Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Sodium Iodide (131I) Diagnostic Capsules Revenue (2020-2031) & (US$ Million)
 Figure 12. Global Sodium Iodide (131I) Diagnostic Capsules Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 13. Global Sodium Iodide (131I) Diagnostic Capsules Revenue Market Share by Region (2020-2031)
 Figure 14. Global Sodium Iodide (131I) Diagnostic Capsules Sales (2020-2031) & (K Units)
 Figure 15. Global Sodium Iodide (131I) Diagnostic Capsules Sales (CAGR) by Region (2020-2031) (K Units)
 Figure 16. Global Sodium Iodide (131I) Diagnostic Capsules Sales Market Share by Region (2020-2031)
 Figure 17. Top 5 and Top 10 Manufacturers Sodium Iodide (131I) Diagnostic Capsules Sales Volume Market Share in 2024
 Figure 18. Global Sodium Iodide (131I) Diagnostic Capsules Revenue Market Share Ranking (2024)
 Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 20. 0.333MBq Revenue Market Share by Manufacturer in 2024
 Figure 21. 3.7MBq Revenue Market Share by Manufacturer in 2024
 Figure 22. Others Revenue Market Share by Manufacturer in 2024
 Figure 23. Global Sodium Iodide (131I) Diagnostic Capsules Sales Market Share by Specification (2020-2031)
 Figure 24. Global Sodium Iodide (131I) Diagnostic Capsules Revenue Market Share by Specification (2020-2031)
 Figure 25. Global Sodium Iodide (131I) Diagnostic Capsules Sales Market Share by Application (2020-2031)
 Figure 26. Global Sodium Iodide (131I) Diagnostic Capsules Revenue Market Share by Application (2020-2031)
 Figure 27. North America Sodium Iodide (131I) Diagnostic Capsules Sales YoY (2020-2031) & (K Units)
 Figure 28. North America Sodium Iodide (131I) Diagnostic Capsules Revenue YoY (2020-2031) & (US$ Million)
 Figure 29. North America Top 5 Manufacturers Sodium Iodide (131I) Diagnostic Capsules Sales Revenue (US$ Million) in 2024
 Figure 30. North America Sodium Iodide (131I) Diagnostic Capsules Sales Volume (K Units) by Specification (2020- 2031)
 Figure 31. North America Sodium Iodide (131I) Diagnostic Capsules Sales Revenue (US$ Million) by Specification (2020 - 2031)
 Figure 32. North America Sodium Iodide (131I) Diagnostic Capsules Sales Volume (K Units) by Application (2020-2031)
 Figure 33. North America Sodium Iodide (131I) Diagnostic Capsules Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 34. US Sodium Iodide (131I) Diagnostic Capsules Revenue (2020-2031) & (US$ Million)
 Figure 35. Canada Sodium Iodide (131I) Diagnostic Capsules Revenue (2020-2031) & (US$ Million)
 Figure 36. Mexico Sodium Iodide (131I) Diagnostic Capsules Revenue (2020-2031) & (US$ Million)
 Figure 37. Europe Sodium Iodide (131I) Diagnostic Capsules Sales YoY (2020-2031) & (K Units)
 Figure 38. Europe Sodium Iodide (131I) Diagnostic Capsules Revenue YoY (2020-2031) & (US$ Million)
 Figure 39. Europe Top 5 Manufacturers Sodium Iodide (131I) Diagnostic Capsules Sales Revenue (US$ Million) in 2024
 Figure 40. Europe Sodium Iodide (131I) Diagnostic Capsules Sales Volume (K Units) by Specification (2020-2031)
 Figure 41. Europe Sodium Iodide (131I) Diagnostic Capsules Sales Revenue (US$ Million) by Specification (2020-2031)
 Figure 42. Europe Sodium Iodide (131I) Diagnostic Capsules Sales Volume (K Units) by Application (2020-2031)
 Figure 43. Europe Sodium Iodide (131I) Diagnostic Capsules Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 44. Germany Sodium Iodide (131I) Diagnostic Capsules Revenue (2020-2031) & (US$ Million)
 Figure 45. France Sodium Iodide (131I) Diagnostic Capsules Revenue (2020-2031) & (US$ Million)
 Figure 46. U.K. Sodium Iodide (131I) Diagnostic Capsules Revenue (2020-2031) & (US$ Million)
 Figure 47. Italy Sodium Iodide (131I) Diagnostic Capsules Revenue (2020-2031) & (US$ Million)
 Figure 48. Russia Sodium Iodide (131I) Diagnostic Capsules Revenue (2020-2031) & (US$ Million)
 Figure 49. Asia-Pacific Sodium Iodide (131I) Diagnostic Capsules Sales YoY (2020-2031) & (K Units)
 Figure 50. Asia-Pacific Sodium Iodide (131I) Diagnostic Capsules Revenue YoY (2020-2031) & (US$ Million)
 Figure 51. Asia-Pacific Top 8 Manufacturers Sodium Iodide (131I) Diagnostic Capsules Sales Revenue (US$ Million) in 2024
 Figure 52. Asia-Pacific Sodium Iodide (131I) Diagnostic Capsules Sales Volume (K Units) by Specification (2020- 2031)
 Figure 53. Asia-Pacific Sodium Iodide (131I) Diagnostic Capsules Sales Revenue (US$ Million) by Specification (2020- 2031)
 Figure 54. Asia-Pacific Sodium Iodide (131I) Diagnostic Capsules Sales Volume (K Units) by Application (2020-2031)
 Figure 55. Asia-Pacific Sodium Iodide (131I) Diagnostic Capsules Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 56. Indonesia Sodium Iodide (131I) Diagnostic Capsules Revenue (2020-2031) & (US$ Million)
 Figure 57. Japan Sodium Iodide (131I) Diagnostic Capsules Revenue (2020-2031) & (US$ Million)
 Figure 58. South Korea Sodium Iodide (131I) Diagnostic Capsules Revenue (2020-2031) & (US$ Million)
 Figure 59. China Taiwan Sodium Iodide (131I) Diagnostic Capsules Revenue (2020-2031) & (US$ Million)
 Figure 60. India Sodium Iodide (131I) Diagnostic Capsules Revenue (2020-2031) & (US$ Million)
 Figure 61. Central and South America Sodium Iodide (131I) Diagnostic Capsules Sales YoY (2020-2031) & (K Units)
 Figure 62. Central and South America Sodium Iodide (131I) Diagnostic Capsules Revenue YoY (2020-2031) & (US$ Million)
 Figure 63. Central and South America Top 5 Manufacturers Sodium Iodide (131I) Diagnostic Capsules Sales Revenue (US$ Million) in 2024
 Figure 64. Central and South America Sodium Iodide (131I) Diagnostic Capsules Sales Volume (K Units) by Specification (2021-2031)
 Figure 65. Central and South America Sodium Iodide (131I) Diagnostic Capsules Sales Revenue (US$ Million) by Specification (2020-2031)
 Figure 66. Central and South America Sodium Iodide (131I) Diagnostic Capsules Sales Volume (K Units) by Application (2020-2031)
 Figure 67. Central and South America Sodium Iodide (131I) Diagnostic Capsules Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 68. Brazil Sodium Iodide (131I) Diagnostic Capsules Revenue (2020-2025) & (US$ Million)
 Figure 69. Argentina Sodium Iodide (131I) Diagnostic Capsules Revenue (2020-2025) & (US$ Million)
 Figure 70. Middle East, and Africa Sodium Iodide (131I) Diagnostic Capsules Sales YoY (2020-2031) & (K Units)
 Figure 71. Middle East and Africa Sodium Iodide (131I) Diagnostic Capsules Revenue YoY (2020-2031) & (US$ Million)
 Figure 72. Middle East and Africa Top 5 Manufacturers Sodium Iodide (131I) Diagnostic Capsules Sales Revenue (US$ Million) in 2024
 Figure 73. Middle East and Africa Sodium Iodide (131I) Diagnostic Capsules Sales Volume (K Units) by Specification (2021-2031)
 Figure 74. South America Sodium Iodide (131I) Diagnostic Capsules Sales Revenue (US$ Million) by Specification (2020-2031)
 Figure 75. Middle East and Africa Sodium Iodide (131I) Diagnostic Capsules Sales Volume (K Units) by Application (2020-2031)
 Figure 76. Middle East and Africa Sodium Iodide (131I) Diagnostic Capsules Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 77. GCC Countries Sodium Iodide (131I) Diagnostic Capsules Revenue (2020-2025) & (US$ Million)
 Figure 78. Turkey Sodium Iodide (131I) Diagnostic Capsules Revenue (2020-2025) & (US$ Million)
 Figure 79. Egypt Sodium Iodide (131I) Diagnostic Capsules Revenue (2020-2025) & (US$ Million)
 Figure 80. South Africa Sodium Iodide (131I) Diagnostic Capsules Revenue (2020-2025) & (US$ Million)
 Figure 81. Sodium Iodide (131I) Diagnostic Capsules Industry Chain Mapping
 Figure 82. Regional Sodium Iodide (131I) Diagnostic Capsules Manufacturing Base Distribution (%)
 Figure 83. Global Sodium Iodide (131I) Diagnostic Capsules Production Market Share by Region (2020-2031)
 Figure 84. Sodium Iodide (131I) Diagnostic Capsules Production Process
 Figure 85. Regional Sodium Iodide (131I) Diagnostic Capsules Production Cost Structure
 Figure 86. Channels of Distribution (Direct Vs Distribution)
 Figure 87. Bottom-up and Top-down Approaches for This Report
 Figure 88. Data Triangulation
 Figure 89. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

SIMILAR REPORTS

RELATED REPORTS

Global Organic Zinc Supplements Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-38U19850
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Egg Protein Hydrolysates Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-0Z20517
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global PAC Flocculant Dosing Device Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28R19905
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Polyaspartic Acid Magnesium Salt(PASP-Mg) Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-17G20275
Wed Dec 03 00:00:00 UTC 2025

Add to Cart